Enhabit (EHAB) Revenue & Revenue Breakdown
Enhabit Revenue Highlights
Latest Revenue (Y)
$1.03B
Latest Revenue (Q)
$266.10M
Main Segment (Y)
Home Health Segment
Enhabit Revenue by Period
Enhabit Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $1.03B | -1.10% |
| 2023-12-31 | $1.05B | -3.40% |
| 2022-12-31 | $1.08B | -2.12% |
| 2021-12-31 | $1.11B | 2.63% |
| 2020-12-31 | $1.08B | -1.26% |
| 2019-12-31 | $1.09B | - |
Enhabit generated $1.03B in revenue during NA 2024, up -1.10% compared to the previous quarter, and up 94.76% compared to the same period a year ago.
Enhabit Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-06-30 | $266.10M | 2.39% |
| 2025-03-31 | $259.90M | 0.66% |
| 2024-12-31 | $258.20M | 1.81% |
| 2024-09-30 | $253.60M | -2.69% |
| 2024-06-30 | $260.60M | -0.69% |
| 2024-03-31 | $262.40M | 0.69% |
| 2023-12-31 | $260.60M | 0.89% |
| 2023-09-30 | $258.30M | -1.52% |
| 2023-06-30 | $262.30M | -1.06% |
| 2023-03-31 | $265.10M | -3.64% |
| 2022-12-31 | $275.10M | 3.54% |
| 2022-09-30 | $265.70M | -0.86% |
| 2022-06-30 | $268.00M | -2.30% |
| 2022-03-31 | $274.30M | -0.65% |
| 2021-12-31 | $276.10M | 0.80% |
| 2021-09-30 | $273.90M | -4.26% |
| 2021-06-30 | $286.10M | 5.77% |
| 2021-03-31 | $270.50M | - |
Enhabit generated $266.10M in revenue during Q2 2025, up 2.39% compared to the previous quarter, and up 101.41% compared to the same period a year ago.
Enhabit Revenue Breakdown
Enhabit Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 24 | Dec 23 | Dec 22 |
|---|---|---|---|
| Home Health Segment | $824.80M | $850.10M | $877.10M |
Latest
Enhabit's latest annual revenue breakdown by segment (product or service), as of Dec 24: Home Health Segment (100.00%).
Quarterly Revenue by Product
| Product/Service | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Home Health Segment | $200.50M | $205.90M | $200.60M | $410.60M | $201.00M | $213.20M | $209.60M | $210.90M | $213.80M | $215.80M | $215.70M | $216.30M | $220.20M |
Latest
Enhabit's latest quarterly revenue breakdown by segment (product or service), as of Sep 25: Home Health Segment (100.00%).
Enhabit Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| AGL | Agilon Health | $6.06B | $1.44B |
| AUNA | Auna | $1.04B | $286.20M |
| EHAB | Enhabit | $1.03B | $266.10M |
| TOI | Oncology Institute | $393.41M | $136.56M |
| SNDA | Sonida Senior Living | $304.33M | $98.04M |
| KIDS | OrthoPediatrics | $204.73M | $61.25M |
| LAB | Standard BioTools | $174.43M | $19.55M |
| CBLL | CeriBell | $45.23M | $22.59M |
| AUTL | Autolus Therapeutics | $10.12M | $21.14M |
| QSI | Quantum-Si | $3.06M | $552.00K |
| CCRN | Cross Country Healthcare | - | - |